Astellas To Sell Low-Margin Drug Plant To Nichi-Iko For Outsourcing
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma reportedly plans to sell to Nichi-Iko Pharmaceutical its 400-employee plant in Fuji, Japan, to serve as an outsource production site for the seller.